Metformin is a commonly prescribed medication for millions of people with diabetes to help control their blood sugar levels. It is often used for long-term management of the disease.
However, recent research has raised concerns that discontinuing metformin early may be linked to an increased risk of developing cognitive problems as individuals age.
A study conducted by researchers at Boston University found that staying on metformin appeared to have a protective effect against the onset of dementia.
Individuals who stopped taking metformin prematurely were found to be 21% more likely to be diagnosed with dementia compared to those who continued taking the medication.
Sarah Ackley, an epidemiologist at Boston University, emphasized the importance of staying on metformin unless contraindicated.
Some people may discontinue metformin due to side effects, such as kidney problems, or because they prefer managing their blood sugar without medication.
The study focused on people with type 2 diabetes and examined new cases of dementia.
It involved 12,220 individuals who had discontinued metformin and 29,000 who continued taking the medication, utilizing data from the Kaiser Permanente Northern California health care system.
However, the study did not determine the exact mechanism by which metformin may prevent age-related memory changes.
The Role of Metformin’s Other Effects
The research suggests that metformin’s potential to lower dementia risk may be related to its broader benefits beyond diabetes management.
The study’s author, Scott Zimmerman, an epidemiologist at the University of California, San Francisco, believes that factors beyond blood sugar control are likely responsible.
Understanding these effects could lead to more effective interventions and preventive strategies in future research.
Experts stress the importance of consulting with a healthcare provider before considering discontinuing metformin.
Each individual’s situation is unique, and factors such as dementia risk, metformin side effects, and patient preferences need to be carefully balanced.
The potential benefits of metformin in preventing complications beyond diabetes should be part of the conversation between patients and their healthcare providers.
These findings align with previous research indicating that metformin may reduce the risk of developing dementia.
Yuko Hara, director of Aging and Alzheimer’s Prevention at the Alzheimer’s Drug Discovery Foundation, notes that type 2 diabetes and Alzheimer’s disease share several characteristics, including impaired glucose uptake into the brain.
Glucose is essential for brain function, and both conditions are associated with insulin resistance and increased oxidative stress.
Dr. John Buse, director of the Diabetes Care Center at the University of North Carolina at Chapel Hill, emphasizes the need for more study before drawing definitive conclusions.
Concerns have been raised about metformin’s potential to lower vitamin B12 levels, which could contribute to memory and thinking issues. Buse suggests that discontinuing metformin may be a symptom rather than a cause of dementia.
While the study’s findings raise intriguing questions, it is important to approach them with caution. Metformin remains a widely used and effective medication for diabetes management.
The decision to discontinue it should be made on an individual basis, considering factors such as kidney health and patient preferences.
Further research is needed to explore the relationship between metformin and dementia risk comprehensively. For now, metformin continues to play a crucial role in helping individuals manage their diabetes and maintain their overall health.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and what you need to know about avocado and type 2 diabetes.
For more information about diabetes, please see recent studies about how to eat to prevent type 2 diabetes, and 5 vitamins that may prevent complication in diabetes.
The research findings can be found in JAMA Network Open.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
